Page
%P
![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Open AccessGenome wide association study and genomic risk prediction of age related macular degeneration in Israel
The risk of develo** age-related macular degeneration (AMD) is influenced by genetic background. In 2016, the International AMD Genomics Consortium (IAMDGC) identified 52 risk variants in 34 loci, and a poly...
-
Article
Molecular Biomarkers for Glaucoma
This article summarizes the current studies on molecular biomarkers with potential implications in diagnosis, prognosis, and response to treatment in patients with glaucoma.
-
Article
Open AccessBevacizumab treatment for neovascular age-related macular degeneration in the setting of a clinic: “real life” long-term outcome
To evaluate the long-term outcome of bevacizumab therapy for neovascular age related macular degeneration (NVAMD) in the setting of a clinic.